Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Infection and Drug Resistance|May 2, 2017
Drug resistance in influenza A virus: the epidemiology and managementMazhar Hussain, Henry D Galvin, Tatt Y Haw, et al.Internal Medicine Journal|October 6, 2012
Total arterial coronary artery bypass grafting in patients with diabetes: an 8-year experienceB F Buxton, W Y Shi, S D Galvin, et al.Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996
Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimerasB D Galvin, K C Hart, A N Meyer, et al.Respiratory Physiology & Neurobiology|March 5, 2011
Profound hyperventilation and development of periodic breathing during exceptional orthostatic stress in a 21-year-old manJoseph Donnelly, Samuel J E Lucas, Kate N Thomas, et al.The Journal of Physiology|November 26, 2009
Influence of baroreflex-mediated tachycardia on the regulation of dynamic cerebral perfusion during acute hypotension in humansShigehiko Ogoh, Yu-Chieh Tzeng, Samuel J E Lucas, et al.Journal of Human Hypertension|December 18, 2009
Identical pattern of cerebral hypoperfusion during different types of syncopeK N Thomas, S D Galvin, M J A Williams, et al.Irish Medical Journal|July 25, 2017
The Hidden Burden of Outpatient Repeat PSA Testing in a Prospective CohortE Browne, K O'Malley, S Connolly, et al.Aorta (Stamford, Conn.)|January 23, 2016
Outcomes of Aortic Arch Replacement Performed Without Circulatory Arrest or Deep HypothermiaNisal K Perera, William Y Shi, Rhiannon S Koirala, et al.Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domainS C Robertson, A N Meyer, K C Hart, et al.American Journal of Clinical Oncology|April 1, 1994
Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study GroupL X Cubeddu, K Pendergrass, T Ryan, et al.Pageof 6